| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Rahimeh Emamnejad, Maurice Pagnin, Steven Petrato. The Iron Maiden: Oligodendroglial metabolic disfunction in multiple sclerosis and mitochondrial signalling. Neuroscience and biobehavioral reviews. 2024-07-01. PMID:38950685. |
multiple sclerosis (ms) is an autoimmune disease, governed by oligodendrocyte (ol) dystrophy and central nervous system (cns) demyelination manifesting variable neurological impairments. |
2024-07-01 |
2024-07-04 |
Not clear |
| Àlex Rovira, Angela Vidal-Jordana, Cristina Auger, Jaume Sastre-Garrig. Optic Nerve Imaging in Multiple Sclerosis and Related Disorders. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942524. |
optic neuritis is a common feature in multiple sclerosis and in 2 other autoimmune demyelinating disorders such as aquaporin-4 igg antibody-associated neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2024-06-28 |
2024-07-01 |
Not clear |
| János György Pitter, László Nagy, Balázs Nagy, Rok Hre. Development Perspectives for Curative Technologies in Primary Demyelinating Disorders of the Central Nervous System with Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) at the Forefront. Journal of personalized medicine. vol 14. issue 6. 2024-06-27. PMID:38929820. |
primary demyelinating disorders of the central nervous system (cns) include multiple sclerosis and the orphan conditions neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein igg-associated disease (mogad). |
2024-06-27 |
2024-06-29 |
Not clear |
| Maria Rodi, Anne-Lise de Lastic, Ioannis Panagoulias, Ioanna Aggeletopoulou, Kostas Kelaidonis, John Matsoukas, Vasso Apostolopoulos, Athanasia Mouzak. Myelin Oligodendrocyte Glycoprotein (MOG)35-55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis. International journal of molecular sciences. vol 25. issue 11. 2024-06-19. PMID:38892275. |
myelin oligodendrocyte glycoprotein (mog)35-55 mannan conjugate induces human t-cell tolerance and can be used as a personalized therapy for multiple sclerosis. |
2024-06-19 |
2024-06-21 |
mouse |
| Wenjing Luo, Xiaonan Zhong, Shishi Shen, Ling Fang, Yiying Huang, Yuge Wang, Wei Qi. A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis. European journal of neurology. 2024-06-12. PMID:38863307. |
a comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis. |
2024-06-12 |
2024-06-14 |
Not clear |
| Wenjing Luo, Xiaonan Zhong, Shishi Shen, Ling Fang, Yiying Huang, Yuge Wang, Wei Qi. A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis. European journal of neurology. 2024-06-12. PMID:38863307. |
we aimed to characterize hypothalamic involvement in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) and compare it with neuromyelitis optica spectrum disorder (nmosd) and multiple sclerosis (ms). |
2024-06-12 |
2024-06-14 |
Not clear |
| Abudurousuli Adili, Aerken Dilihumaer, Huhu Zhu, Huifang Tan. Research progress on phosphodiesterase 4 inhibitors in central nervous system diseases. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences. 2024-06-11. PMID:38860393. |
pde4 inhibitors can also promote the differentiation of oligodendrocyte progenitor cells and enhance myelination, which has potential in the treatment of multiple sclerosis. |
2024-06-11 |
2024-06-14 |
Not clear |
| Yuqing Wu, Hao Zhou, Xiaojiao Ci, Jie L. Low T3 syndrome is associated with the severity of myelin oligodendrocyte glycoprotein antibody-associated disease exacerbation. Frontiers in neuroscience. vol 18. 2024-06-05. PMID:38835837. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is a rare autoimmune inflammatory disease of the central nervous system, (cns) different from multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (nmosd). |
2024-06-05 |
2024-06-07 |
Not clear |
| Larissa Jank, Riley B Catenacci, Veronica Minney, Danny Galleguillos, Peter A Calabres. Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2024-05-26. PMID:38797642. |
pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro. |
2024-05-26 |
2024-05-31 |
mouse |
| Rosa Cortese, Marco Battaglini, Ferran Prados, Giordano Gentile, Ludovico Luchetti, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Romain Marignier, Françoise Durand-Dubief, Carolina de Medeiros Rimkus, Samira Luisa Apostolos Pereira, Douglas Kazutoshi Sato, Massimo Filippi, Maria Assunta Rocca, Laura Cacciaguerra, Àlex Rovira, Jaume Sastre-Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriu, Maria Sepulveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth G Celius, Anne-Katrin Pröbstel, Cristina Granziera, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Frederik Barkhof, Olga Ciccarelli, Nicola De Stefan. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis. Annals of neurology. 2024-05-23. PMID:38780377. |
grey matter atrophy and its relationship with white matter lesions in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder, and multiple sclerosis. |
2024-05-23 |
2024-05-27 |
Not clear |
| Rosa Cortese, Marco Battaglini, Ferran Prados, Giordano Gentile, Ludovico Luchetti, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Romain Marignier, Françoise Durand-Dubief, Carolina de Medeiros Rimkus, Samira Luisa Apostolos Pereira, Douglas Kazutoshi Sato, Massimo Filippi, Maria Assunta Rocca, Laura Cacciaguerra, Àlex Rovira, Jaume Sastre-Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriu, Maria Sepulveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth G Celius, Anne-Katrin Pröbstel, Cristina Granziera, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Frederik Barkhof, Olga Ciccarelli, Nicola De Stefan. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis. Annals of neurology. 2024-05-23. PMID:38780377. |
to evaluate: (1) the distribution of gray matter (gm) atrophy in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (aqp4+nmosd), and relapsing-remitting multiple sclerosis (rrms); and (2) the relationship between gm volumes and white matter lesions in various brain regions within each disease. |
2024-05-23 |
2024-05-27 |
Not clear |
| Niroshan Jeyakumar, Magdalena Lerch, Russell C Dale, Sudarshini Ramanatha. MOG antibody-associated optic neuritis. Eye (London, England). 2024-05-23. PMID:38783085. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is a demyelinating disorder, distinct from multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (nmosd). |
2024-05-23 |
2024-05-27 |
Not clear |
| Y Labrak, M Alhouayek, A Mwema, L d'Auria, B Ucakar, V van Pesch, G G Muccioli, A des Rieu. The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal administration. International journal of pharmaceutics. 2024-05-18. PMID:38762167. |
as the hallmarks of multiple sclerosis (ms) are neuroinflammation and oligodendrocyte loss, our hypothesis was that by combining two molecules known for their pro-differentiating properties, encapsulated in lnc, and delivered by intranasal administration, we would stimulate oligodendrocyte progenitor cells (opc) differentiation into oligodendrocytes and provide a new pro-remyelinating therapy. |
2024-05-18 |
2024-05-27 |
mouse |
| Roopa Ravichandar, Farah Gadelkarim, Rupadevi Muthaiah, Nicolas Glynos, Kateryna Murlanova, Nagendra K Rai, Darpan Saraswat, Jessie J Polanco, Ranjan Dutta, Dinesh Pal, Fraser J Si. Dysregulated cholinergic signaling inhibits oligodendrocyte maturation following demyelination. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2024-05-15. PMID:38749703. |
dysregulation of oligodendrocyte progenitor cell (opc) recruitment and oligodendrocyte differentiation contribute to failure of remyelination in human demyelinating diseases such as multiple sclerosis (ms). |
2024-05-15 |
2024-05-27 |
mouse |
| Ritu R Trivedi, Angela S Archambault, Clarice Pavlak, Matteo Gastaldi, Claudia Cantoni, Laura Ghezzi, Anne H Cross, Timothy M Miller, Gregory F W. Prevalence of anti-myelin oligodendrocyte glycoprotein antibodies across neuroinflammatory and neurodegenerative diseases. Journal of the neurological sciences. vol 461. 2024-05-14. PMID:38744216. |
inflammatory central nervous system (cns) diseases, such as multiple sclerosis (ms) and myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad), are characterized by humoral immune abnormalities. |
2024-05-14 |
2024-05-27 |
human |
| Tapio Nevalainen, Arttu Autio-Kimura, Mikko Hurm. Human endogenous retrovirus W in multiple sclerosis: transcriptional activity is associated with decline in oligodendrocyte proportions in the white matter of the brain. Journal of neurovirology. 2024-05-08. PMID:38717678. |
human endogenous retrovirus w in multiple sclerosis: transcriptional activity is associated with decline in oligodendrocyte proportions in the white matter of the brain. |
2024-05-08 |
2024-05-27 |
human |
| Ramakrishna Prithviraj, Bidisha Banerjee, Ullas V Acharya, Muhammed Hafis, Sruthi Sashidhara. Clinico-radiologic Spectrum and Outcome of Pediatric Acquired Demyelinating Disorders of Central Nervous System: A Retrospective Indian Tertiary Care Hospital Cohort. Neuropediatrics. 2024-05-07. PMID:38641336. |
we describe clinico-radiologic spectrum, outcomes, and comparison of the groups: acute disseminated encephalomyelitis (adem), neuromyelitis optica spectrum disorder (nmosd), clinically isolated syndrome (cis), multiple sclerosis (ms), and myelin oligodendrocyte glycoprotein antibody-associated disorders (mogad). |
2024-05-07 |
2024-05-27 |
Not clear |
| Laura Cacciaguerra, Omar Abdel-Mannan, Dimitrios Champsas, Kshitij Mankad, Karl N Krecke, John J Chen, Stephanie B Syc-Mazurek, Vyanka Redenbaugh, Alfonso S Lopez-Chiriboga, Cristina Valencia-Sanchez, Cheryl Hemingway, Jan-Mendelt Tillema, Olga Ciccarelli, Sean J Pittock, Yael Hacohen, Eoin P Flanaga. Radiologic Lag and Brain MRI Lesion Dynamics During Attacks in MOG Antibody-Associated Disease. Neurology. vol 102. issue 10. 2024-05-06. PMID:38710000. |
we evaluated intra-attack lesion dynamics in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) vs multiple sclerosis (ms) and aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder (aqp4+nmosd). |
2024-05-06 |
2024-05-27 |
Not clear |
| Xuezhao Liu, Dazhuan Eric Xin, Xiaowen Zhong, Chuntao Zhao, Zhidan Li, Liguo Zhang, Adam J Dourson, Lindsay Lee, Shreya Mishra, Arman E Bayat, Eva Nicholson, William L Seibel, Bingfang Yan, Joel Mason, Bradley J Turner, David G Gonsalvez, William Ong, Sing Yian Chew, Balaram Ghosh, Sung Ok Yoon, Mei Xin, Zhigang He, Jason Tchieu, Michael Wegner, Klaus-Armin Nave, Robin J M Franklin, Ranjan Dutta, Bruce D Trapp, Ming Hu, Matthew A Smith, Michael P Jankowski, Samantha K Barton, Xuelian He, Q Richard L. Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration. Cell. 2024-05-03. PMID:38701782. |
remyelination failure in diseases like multiple sclerosis (ms) was thought to involve suppressed maturation of oligodendrocyte precursors; however, oligodendrocytes are present in ms lesions yet lack myelin production. |
2024-05-03 |
2024-05-06 |
mouse |
| Alessia Bianchi, Rosa Cortese, Ferran Prados, Carmen Tur, Baris Kanber, Marios C Yiannakas, Rebecca Samson, Floriana De Angelis, Lise Magnollay, Anu Jacob, Wallace Brownlee, Anand Trip, Richard Nicholas, Yael Hacohen, Frederik Barkhof, Olga Ciccarelli, Ahmed T Toos. Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease. Multiple sclerosis (Houndmills, Basingstoke, England). 2024-04-22. PMID:38646958. |
optic neuritis (on) is a common feature of inflammatory demyelinating diseases (idds) such as multiple sclerosis (ms), aquaporin 4-antibody neuromyelitis optica spectrum disorder (aqp4 + nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2024-04-22 |
2024-04-26 |
Not clear |